Integrum AB (FRA:6Y1) Cyclically Adjusted Revenue per Share: €0.30 (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:6Y1 Integrum AB FRA:6Y1
52 GF Score
Price €0.69
GF Value €1.54
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Integrum AB Cyclically Adjusted Revenue per Share?

Integrum AB FRA:6Y1 +0.14% 52 Cyclically Adjusted Revenue per Share is €0.30 as of Apr. 2026. GuruFocus rates FRA:6Y1 with a GF Score™ of 52/100 and a GF Value™ of €1.54 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Integrum AB's adjusted revenue per share for the three months ended in Apr. 2026 was €0.087. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €0.30 for the trailing ten years ended in Apr. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-08), Integrum AB's current stock price is €0.693. Integrum AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Apr. 2026 was €0.30. Integrum AB's Cyclically Adjusted PS Ratio of today is 2.31.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Integrum AB was 3.39. The lowest was 2.04. And the median was 2.44.


Integrum AB  (FRA:6Y1) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Integrum AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.693/0.30
=2.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Integrum AB was 3.39. The lowest was 2.04. And the median was 2.44.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Integrum AB Cyclically Adjusted Revenue per Share Related Terms


Integrum AB Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Integrum AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integrum AB Cyclically Adjusted Revenue per Share Chart

Integrum AB Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.30

Integrum AB Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.30 0.32 0.30

FRA:6Y1 vs ABT, SYK, MDT: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Integrum AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integrum AB Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Integrum AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Integrum AB's Cyclically Adjusted PS Ratio falls into.


FRA:6Y1
52GF Score
Integrum AB FRA:6Y1
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Integrum AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Integrum AB's adjusted Revenue per Share data for the three months ended in Apr. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Apr. 2026 (Change)*Current CPI (Apr. 2026)
=0.087/132.7900*132.7900
=0.087

Current CPI (Apr. 2026) = 132.7900.

Integrum AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201607 0.078 101.080 0.102
201610 0.023 101.485 0.030
201701 0.055 101.326 0.072
201704 0.041 102.615 0.053
201707 0.058 103.301 0.075
201710 0.057 103.202 0.073
201801 0.013 102.925 0.017
201804 0.029 104.390 0.037
201807 0.037 105.420 0.047
201810 0.064 105.545 0.081
201901 0.039 104.855 0.049
201904 0.034 106.627 0.042
201907 0.026 107.166 0.032
201910 0.051 107.243 0.063
202001 0.046 106.215 0.058
202004 0.040 106.240 0.050
202007 0.043 107.731 0.053
202010 0.074 107.539 0.091
202101 0.063 107.897 0.078
202104 0.099 108.624 0.121
202107 0.076 109.218 0.092
202110 0.064 110.562 0.077
202201 0.064 111.876 0.076
202204 0.111 115.534 0.128
202207 0.089 118.489 0.100
202210 0.100 122.561 0.108
202301 0.089 124.942 0.095
202304 0.088 127.632 0.092
202307 0.094 129.464 0.096
202310 0.127 130.549 0.129
202401 0.140 131.720 0.141
202404 0.115 132.601 0.115
202407 0.078 132.831 0.078
202410 0.097 132.604 0.097
202501 0.107 132.943 0.107
202504 0.116 132.981 0.116
202507 0.096 133.957 0.095
202510 0.094 133.830 0.093
202601 0.077 133.560 0.077
202604 0.087 132.790 0.087

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €0.30 mean?
Integrum AB (FRA:6Y1) has a Cyclically Adjusted Revenue per Share of €0.30 as of Apr. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Integrum AB and its competitors.
Is Integrum AB's Cyclically Adjusted Revenue per Share too high?
Integrum AB's current Cyclically Adjusted Revenue per Share is €0.30. Overall, Integrum AB has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Integrum AB's Cyclically Adjusted Revenue per Share compare to ABT and SYK?
Integrum AB's Cyclically Adjusted Revenue per Share of €0.30 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Integrum AB and its competitors. Integrum AB's current Cyclically Adjusted Revenue per Share is €0.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integrum AB stock overvalued right now?
Based on GuruFocus' analysis, Integrum AB (FRA:6Y1) is currently considered Possible Value Trap. The stock's GF Value™ is €1.54, compared to a current price of €0.69 — trading 55% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €0.30. Integrum AB's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Integrum AB (FRA:6Y1), the current Cyclically Adjusted Revenue per Share is €0.30 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integrum AB (FRA:6Y1) Overvalued in 2026?

Based on GuruFocus' analysis, Integrum AB stock appears to be undervalued. The current stock price of €0.69 is trading 55% below its estimated GF Value™ of €1.54. GuruFocus considers Integrum AB to be Possible Value Trap.

Key valuation signals for FRA:6Y1:

  • Cyclically Adjusted Revenue per Share: €0.30
  • GF Value™: €1.54 vs. price of €0.69 (55% below fair value)
  • GF Score™: 52/100 with 4 warning signs

No single metric tells the full story. See the FRA:6Y1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Integrum AB Business Description

Other Exchanges INTEG B:Sweden
Address Krokslatts Fabriker 50, Molndal, SWE, SE-431 37
Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.
52GF Score

Get the complete analysis for FRA:6Y1

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.69
Price
€1.54
GF Value